Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell Carcinoma

BACKGROUND: In patients with metastatic renal cell carcinoma (mRCC), the timing of systemic targeted therapy in relation to cytoreductive nephrectomy (CN) is under investigation. OBJECTIVE: To evaluate postoperative complications after the use of presurgical targeted therapy prior to CN. DESIGN, SET...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Eur Urol
Главные авторы: Chapin, Brian F, Delacroix, Scott E, Culp, Stephen H., Nogueras Gonzalez, Graciela M., Tannir, Nizar M., Jonasch, Eric, Tamboli, Pheroz, Wood, Christopher G.
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4378825/
https://ncbi.nlm.nih.gov/pubmed/21621907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2011.05.032
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы